ERBB2 and breast carcinoma: We here obtained the mRNAsi value of 190 basal, 82 Her2, 566 luminal A, and 214 luminal B patient samples as well as136 normal controls and found that significant differences exist in the mRNAsi value of different breast cancer subtypes.